| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant metronomic chemotherapy for locoregionally advanced nasopharyngeal carcinoma
|
Kerbel, Robert S
|
|
|
398 |
10297 |
p. 278-279
|
article
|
| 2 |
Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
|
Redjoul, Rabah
|
|
|
398 |
10297 |
p. 298-299
|
article
|
| 3 |
A strategy to reduce the carbon footprint of clinical trials
|
Adshead, Fiona
|
|
|
398 |
10297 |
p. 281-282
|
article
|
| 4 |
A time of crisis for the opioid epidemic in the USA
|
The Lancet,
|
|
|
398 |
10297 |
p. 277
|
article
|
| 5 |
Cheryl Moyer: egalitarian in global health research
|
Clark, Jocalyn
|
|
|
398 |
10297 |
p. 291
|
article
|
| 6 |
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
|
Berdeja, Jesus G
|
|
|
398 |
10297 |
p. 314-324
|
article
|
| 7 |
Contrast-associated acute kidney injury in a patient with lower respiratory tract infection
|
Cichowitz, Cody
|
|
|
398 |
10297 |
p. 340
|
article
|
| 8 |
FDA approval of dapagliflozin for chronic kidney disease: a remarkable achievement?
|
Jafar, Tazeen H
|
|
|
398 |
10297 |
p. 283-284
|
article
|
| 9 |
Five priorities for universal COVID-19 vaccination
|
Abecassis, Adrien
|
|
|
398 |
10297 |
p. 285-286
|
article
|
| 10 |
Helen Mae Murray Free
|
Watts, Geoff
|
|
|
398 |
10297 |
p. 296
|
article
|
| 11 |
Heterogeneity of treatment effects in malignant pleural mesothelioma
|
Di Maio, Massimo
|
|
|
398 |
10297 |
p. 301-302
|
article
|
| 12 |
Heterogeneity of treatment effects in malignant pleural mesothelioma – Authors' reply
|
Baas, Paul
|
|
|
398 |
10297 |
p. 302
|
article
|
| 13 |
Inquest begins over South African mental health failings
|
Scher, Marion
|
|
|
398 |
10297 |
p. 288
|
article
|
| 14 |
Lack of medicines in Mexico
|
Agren, David
|
|
|
398 |
10297 |
p. 289-290
|
article
|
| 15 |
Mass infection is not an option: we must do more to protect our young
|
Gurdasani, Deepti
|
|
|
398 |
10297 |
p. 297-298
|
article
|
| 16 |
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
|
Chen, Yu-Pei
|
|
|
398 |
10297 |
p. 303-313
|
article
|
| 17 |
Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study
|
|
|
|
398 |
10297 |
p. 325-339
|
article
|
| 18 |
Paediatric surgery for congenital anomalies: the next frontier for global health
|
Stokes, Sarah C
|
|
|
398 |
10297 |
p. 280-281
|
article
|
| 19 |
Past and present women pioneers in biomedical science
|
Marks, Lara
|
|
|
398 |
10297 |
p. 293-295
|
article
|
| 20 |
Physical punishment and child outcomes: a narrative review of prospective studies
|
Heilmann, Anja
|
|
|
398 |
10297 |
p. 355-364
|
article
|
| 21 |
Portrait or snapshot?
|
Kneebone, Roger
|
|
|
398 |
10297 |
p. 292
|
article
|
| 22 |
Pre-eclampsia
|
Chappell, Lucy C
|
|
|
398 |
10297 |
p. 341-354
|
article
|
| 23 |
Social unrest disrupts South African health care
|
Makoni, Munyaradzi
|
|
|
398 |
10297 |
p. 287
|
article
|
| 24 |
The nutrition agenda must include tobacco control
|
Klein, Jonathan D
|
|
|
398 |
10297 |
p. 300-301
|
article
|
| 25 |
The nutrition agenda must include tobacco control – Authors' reply
|
Victora, Cesar G
|
|
|
398 |
10297 |
p. 301
|
article
|
| 26 |
Tocilizumab in COVID-19 therapy: who benefits, and how?
|
Yang, Chengliang
|
|
|
398 |
10297 |
p. 299
|
article
|
| 27 |
Tocilizumab in COVID-19 therapy: who benefits, and how?
|
Neumann, Avidan U
|
|
|
398 |
10297 |
p. 299-300
|
article
|
| 28 |
Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply
|
Horby, Peter
|
|
|
398 |
10297 |
p. 300
|
article
|
Journal description